News Conference News ESC 2025 ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD L.A. McKeown September 09, 2025
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024
News Conference News ESC 2022 First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory L.A. McKeown August 26, 2022
News Conference News HRS 2022 Evidence Grows for Conduction-System Pacing as an Alternative to CRT Todd Neale May 05, 2022
News Conference News THT 2022 LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety Caitlin E. Cox February 02, 2022
News Conference News THT 2022 REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF Shelley Wood February 01, 2022
News Conference News ESC Heart Failure 2019 Device-Based Therapy Offers REPRIEVE From Decongestion in Acute HF: TARGET 1 and 2 Shelley Wood May 25, 2019
News Conference News TCT 2018 Denervation Has Possible Benefit for Pulmonary Hypertension Related to Left Heart Failure Todd Neale September 23, 2018
News Conference News ESC 2018 My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More Shelley Wood September 14, 2018
News Conference News ESC 2018 MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis Todd Neale August 26, 2018
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Conference News AHA 2017 Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I Michael O'Riordan November 21, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017